Journey Medical Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $14.63M Beat $14.39M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 115 percent decrease over earnings of $0.80 per share from the
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 115 percent decrease over earnings of $0.80 per share from the same period last year. The company reported quarterly sales of $14.63 million which beat the analyst consensus estimate of $14.39 million by 1.68 percent. This is a 57.64 percent decrease over sales of $34.54 million the same period last year.